QA: Trevena INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001429560_2022_Trevena_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001429560, Trevena INC

  xvar xval
0 AssetsCurrent 70,723,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,841,000
3 remainder_Assets 7,560,000
4 LiabilitiesCurrent 9,186,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 6,309,000
7 CostOfGoodsAndServicesSold 4,813,999
8 SellingGeneralAndAdministrativeExpense 68,595,595
9 ResearchAndDevelopmentExpense 13,368,741
10 remainder_Expenses 0
11 remainder_Revenues 985,042
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 30,454
  yvar yval
0 Assets 80,124,000
1 Liabilities 15,495,000
2 Expenses 86,778,335
3 Revenues 985,042
4 StockholdersEquity 64,629,000
5 NetIncome -85,793,293
6 ComprehensiveNetIncome -85,778,066
7 BaseVar 91,706,416
8 EconomicCapitalRatiobeforeLimitedLiability 1.15
9 EconomicCapitalRatio 2.42

Edgar->Model Mapping

Feature Distribution

Change over Time